Stock Region Watchlist
Your Mid-Week Market Movers 📈
Your Mid-Week Market Movers 📈
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This is not financial advice. The content of this newsletter is for informational and educational purposes only. I am not a financial advisor, and the stocks mentioned here are part of my personal watchlist, not recommendations to buy or sell. Always do your own research before making any investment decisions.
Here’s your watchlist for Wednesday, November 19, 2025. Let’s get into what’s moving the market and what I’m keeping a close eye on.
Today’s Watchlist
Here’s what’s on the radar today:
Target Corporation ($TGT): The Holiday Spending Gamble
Lowe’s Companies, Inc. ($LOW): Building on Strong Earnings
Viking Therapeutics, Inc. ($VKTX): The Biotech Wildcard
Bullish ($BLSH): Riding the Momentum Wave
Target Corporation ($TGT)
Target just dropped its Q3 results, and it’s a mixed bag. Sales hit a hefty $25.3 billion, but the company is waving a red flag about the upcoming holiday season. They’re worried that high prices will keep shoppers’ wallets closed.
My Take: Target is a retail titan, no doubt. But with inflation pinching everyone’s budget, this holiday season is a massive question mark. Will Black Friday deals be enough to lure people in? TGT’s performance will be a real test of consumer strength. We’m watching to see how they manage these choppy waters. A weak holiday showing could definitely put pressure on the stock.
Lowe’s Companies, Inc. ($LOW)
On the flip side of retail, Lowe’s is absolutely crushing it. They sailed past their Q3 earnings expectations and even raised their full-year guidance. That’s the kind of confidence We love to see from a company’s leadership.
The home improvement trend is clearly still going strong. Lowe’s is executing its plan beautifully and reaping the rewards. For me, this is a sign of solid operational strength. We’re watching a couple of key levels for short-term moves: We’m looking for a break above $232.78 for a potential leg up, or a dip below $231.60 if it faces resistance.
Viking Therapeutics, Inc. ($VKTX)
Now for a little spice. Viking is a biotech play focused on metabolic disorders. These kinds of stocks are not for the faint of heart. Their entire world can change in an instant based on clinical trial news.
VKTX is a high-risk, high-reward situation. You’re not investing in Q3 earnings here; you’re betting on future scientific breakthroughs. We keep stocks like this on the watchlist because one positive press release about a drug trial can send the price soaring. We’ll be keeping my ears to the ground for any pipeline updates. It’s a pure speculation play, but an exciting one to follow.
Bullish ($BLSH)
The name says it all, doesn’t it? Trading at $36.58, BLSH has some serious positive sentiment behind it. That Price-to-Earnings (P/E) ratio of over 100 tells you that investors are expecting big things and are willing to pay a premium for it.
When a stock has this much hype, you have to pay attention. The market loves BLSH right now. However, a high P/E also means high expectations. If the company stumbles even a little, the fall could be swift. I’m watching this for momentum. It could keep running, but we’m also cautious about the potential for volatility. It’s a fascinating one to track.
That’s a wrap for today! Keep your research sharp and your strategy clear.
Happy trading,
The Stock Region Team
Final Disclaimer: Investing involves risk, including the potential loss of principal. The opinions expressed in this newsletter are personal and subject to change. Please consult with a licensed financial professional before making any investment decisions. We are not liable for any losses you may incur.
TGT's cautios guidance for the holiday season is exactly what Im watching across retail right now. The contrast with LOW's confidence makes it even more intresting. Target's Q3 beat on sales but the margins tell a different story when you dig into the promotions they had to run. If discretionary spending stalls further, their comp store sales could get ugly fast.